Banga JD - Search Results

1

Variability of flow mediated dilation: consequences for clinical application.

Hijmering ML, Stroes ES, Pasterkamp G, Sierevogel M, Banga JD, Rabelink TJ. Hijmering ML, et al. Among authors: banga jd. Atherosclerosis. 2001 Aug;157(2):369-73. doi: 10.1016/s0021-9150(00)00748-6. Atherosclerosis. 2001. PMID: 11472736

2

NO activity in familial combined hyperlipidemia: potential role of cholesterol remnants.

Stroes E, de Bruin T, de Valk H, Erkelens W, Banga JD, van Rijn H, Koomans H, Rabelink T. Stroes E, et al. Among authors: banga jd. Cardiovasc Res. 1997 Dec;36(3):445-52. doi: 10.1016/s0008-6363(97)00199-5. Cardiovasc Res. 1997. PMID: 9534865 Clinical Trial.

3

Effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on postprandial endothelial function.

Wilmink HW, Banga JD, Hijmering M, Erkelens WD, Stroes ES, Rabelink TJ. Wilmink HW, et al. Among authors: banga jd. J Am Coll Cardiol. 1999 Jul;34(1):140-5. doi: 10.1016/s0735-1097(99)00154-0. J Am Coll Cardiol. 1999. PMID: 10400003 Free article. Clinical Trial.

4

Influence of folic acid on postprandial endothelial dysfunction.

Wilmink HW, Stroes ES, Erkelens WD, Gerritsen WB, Wever R, Banga JD, Rabelink TJ. Wilmink HW, et al. Among authors: banga jd. Arterioscler Thromb Vasc Biol. 2000 Jan;20(1):185-8. doi: 10.1161/01.atv.20.1.185. Arterioscler Thromb Vasc Biol. 2000. PMID: 10634816 Clinical Trial.

5

Effect of statin versus fibrate on postprandial endothelial dysfunction: role of remnant-like particles.

Wilmink HW, Twickler MB, Banga JD, Dallinga-Thie GM, Eeltink H, Erkelens DW, Rabelink TJ, Stroes ES. Wilmink HW, et al. Among authors: banga jd. Cardiovasc Res. 2001 Jun;50(3):577-82. doi: 10.1016/s0008-6363(01)00227-9. Cardiovasc Res. 2001. PMID: 11376633 Clinical Trial.

6

Is plaque formation in the common carotid artery representative for plaque formation and luminal stenosis in other atherosclerotic peripheral arteries? A post mortem study.

Pasterkamp G, Schoneveld AH, Hillen B, Banga JD, Haudenschild CC, Borst C. Pasterkamp G, et al. Among authors: banga jd. Atherosclerosis. 1998 Mar;137(1):205-10. doi: 10.1016/s0021-9150(97)00255-4. Atherosclerosis. 1998. PMID: 9568753

7

Nitric oxide availability in diabetes mellitus.

Honing ML, Morrison PJ, Banga JD, Stroes ES, Rabelink TJ. Honing ML, et al. Among authors: banga jd. Diabetes Metab Rev. 1998 Sep;14(3):241-9. doi: 10.1002/(sici)1099-0895(1998090)14:3<241::aid-dmr216>3.0.co;2-r. Diabetes Metab Rev. 1998. PMID: 9816472 Review.

8

Homocysteine and the stage of atherosclerotic disease: a study in patients suffering from clinically silent and clinically manifest atherosclerotic disease.

Pasterkamp G, Algra A, Grobbee DE, de Jaegere PP, Banga JD, van der Graaf Y. Pasterkamp G, et al. Among authors: banga jd. Eur J Clin Invest. 2002 May;32(5):309-15. doi: 10.1046/j.1365-2362.2002.00986.x. Eur J Clin Invest. 2002. PMID: 12027869

9

Lipoprotein (a) is associated with endothelial function in healthy postmenopausal women.

Wilmink HW, de Kleijn MJ, Bots ML, Bak AA, van der Schouw YT, Engelen S, Planellas J, Banga J, Grobbee DE. Wilmink HW, et al. Atherosclerosis. 2000 Nov;153(1):249-54. doi: 10.1016/s0021-9150(00)00411-1. Atherosclerosis. 2000. PMID: 11058721

10

The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm.

Olijhoek JK, van der Graaf Y, Banga JD, Algra A, Rabelink TJ, Visseren FL; SMART Study Group. Olijhoek JK, et al. Among authors: banga jd. Eur Heart J. 2004 Feb;25(4):342-8. doi: 10.1016/j.ehj.2003.12.007. Eur Heart J. 2004. PMID: 14984924

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111 results

Search Page

Filters